Events

Human Brain Project Summit 2023
MAR
Tue
28
MAR
Wed
29
MAR
Thu
30
MAR
Fri
31

This was 2 years ago

Location

Marseille, France

PALAIS DU PHARO, Marseille, France
Programmes
Health

The Human Brain Project Summit 2023 provides an open forum for researchers, policy makers, media and public, to discuss exciting scientific results, the latest developments in the project, and the cutting-edge services and tools available on the EBRAINS Research Infrastructure. Many European advances in the field of neurosciences, health and applications in clinical medicine, as well as brain-derived technologies will be presented. It is also meant to be a valuable moment of exchange, discussion, and feedback.

The Summit is an on-site event with theme “Achievements  and future of digital brain research”.

More information, the detailed programme and registration on the event website. Please be aware this is a paying event.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.